Skip to main content
Premium Trial:

Request an Annual Quote

Pronota CEO Resigns as Firm Raises $4.9M

NEW YORK (GenomeWeb News) – Belgian protein diagnostic firm Pronota recently announced the closing of a Series C financing round that raised €3.7 million ($4.9 million).

The company also announced Nick McCooke has resigned as its CEO and as a board member.

The financing will go toward the completion of protein biomarker studies in support of the company's programs for the development of preeclampsia, ovarian cancer, sepsis, and cardio-renal products. Participants in the round included existing investors LSP; Gimv; Biotech Fund Flanders; KBC Private Equity; Johnson & Johnson Development; VIB; MP Healthcare, MedSciences Capital; and a company founder.

Pronota raised €7.9 million in a Series B round in 2010.

The company also said that McCooke has left the company after six years as CEO in order to pursue opportunities closer to his UK home base. Prior to joining Pronota, McCooke had been the CEO of Solexa.

He is being replaced by Katleen Verleysen, who had been Pronota's COO.

Also, John Berriman is stepping down as chairman of the board and being replaced by Rudy Dekeyser, managing director at VIB, Pronota said.

The company uses mass spectrometry-based technologies for the discovery and validation of biomarkers for diagnostic purposes.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.